OAYLX | VIVIX | OAYLX / VIVIX | |
Total Expense Ratio | 0.87 | 0.04 | 2,175% |
Annual Report Gross Expense Ratio | 0.87 | 0.04 | 2,175% |
Fund Existence | 9 years | 27 years | - |
Gain YTD | 3.077 | 5.124 | 60% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 100000 | 5000000 | 2% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 7.3B | 195B | 4% |
Annual Yield % from dividends | 0.42 | 2.19 | 19% |
Returns for 1 year | 13.13 | 6.23 | 211% |
Returns for 3 years | 61.90 | 35.76 | 173% |
Returns for 5 years | 124.08 | 71.90 | 173% |
Returns for 10 years | N/A | 109.41 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
EARN | 5.99 | 0.06 | +1.01% |
Ellington Credit Company | |||
UDIV | 49.18 | 0.33 | +0.67% |
Franklin US Core Dividend Tilt Index ETF | |||
MSFY | 27.01 | 0.17 | +0.64% |
Kurv Yield Premium Str Microsoft ETF | |||
FBT | 165.47 | 0.28 | +0.17% |
First Trust NYSE Arca Biotech ETF | |||
STOT | 47.15 | -0.01 | -0.02% |
SPDR® DoubleLine Shrt Dur Ttl RetTactETF |